JAX® Mice & Services

This webinar discusses the JAX HuPK^* platform, which consists of several transgenic mouse models that express human FcRn and is useful for therapeutic antibody PK evaluation.

^*Note: HuPK is a registered trademark in the USA and other countries.

This webinar discusses approaches to model generation, including key developmental considerations such as defining research goals, selecting an optimal genetic background, and determining appropriate downstream applications for founder mice.

This webinar explores how to leverage humanized mouse models to expedite preclinical research in biologic therapeutics, covering best practices for model selection, study design, and experimental reproducibility when evaluating biologic drugs, including monoclonal antibodies, bispecific T cell engagers, and CAR therapies.